Skip to Main Content
OUTSOURCE EVERYTHING BUT THE GENIUS™

Go to Main Navigation

Industry Trends

Showing 1 - 10 of 53 posts
Nov 18, 2021

It’s now well known that biopharmaceutical companies are increasingly turning to third-party suppliers to support their research and development...

Nov 16, 2021

Meaghan Loy, Category Director of In Vivo Services at Scientist.com and member of the North American 3Rs Collaborative Board of Directors...

Oct 29, 2021

The field of preclinical oncology research is being hit by a new wave of innovation, specifically innovation in disease model sourcing for drug...

Oct 7, 2021

Biotechnology companies aim to develop products and technologies that can solve the many health-related problems that plague our world today. The...

Sep 10, 2021

New advancements in technology and ever-evolving channels of communication are making the world a smaller, more connected place. One click of a...

Mar 22, 2021

We are excited to introduce our newly expanded category Value, Evidence and Access and the accompanying rebranded Value, Evidence and Access...

Feb 25, 2021

How does AW or the 3Rs impact your current role? Jessie: Animal welfare and the 3Rs impact my work at AWIC daily. The main focus and mission of...

Jun 21, 2020

As businesses begin to reopen, including laboratories, researchers should expect operations to look slightly different. Based on conversations...

Jun 19, 2020

Over the past weeks, Scientist.com has been working hard to listen, learn and implement short-term and long-term changes regarding diversity within...

Feb 26, 2020

Firstly, I’d like to explain to our audience what Austrade does before sharing how beneficial it can be for global biotechs looking to benefit from...